Medication info
Alvistol Tablet 5 mg (Nebivolol Hydrochloride)

Alvistol Tablet 5 mg (Nebivolol Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Nebivolol Hydrochloride›5.45mg / 1 tablet
Manufacturer / importer
Allico Pharmaceutical Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 202503343 · Approved 2025.12.22

Summary

Main use
Treatment of essential hypertension and adjunctive treatment of chronic heart failure in patients aged 70 years or older
Who takes it
Adults
Adult dose
1. Essential hypertension 1) Adults Administer 5mg of nebivolol orally once daily at the same time each day. The blood pressure-lowering effect usually appears after 1~2 weeks of treatment and may, in some cases, appear after 4 weeks. It may be taken with food. 2) Patients with renal impairment The initial dose is 2.5mg of nebivolol administered orally once daily. If necessary, the daily dose may be increased to 5mg. 3) Elderly patients The initial dose in elderly patients aged 65 years and older is 2.5mg of nebivolol once daily. If necessary, the daily dose may be increased to 5mg. Since there is insufficient clinical experience in patients aged 75 years and older, administer with careful monitoring. 2. Chronic heart failure 1) Elderly patients aged 70 years and older This drug should be administered to patients with chronic stable heart failure who have had no history of acute heart failure during the past 6 weeks, and doses of cardiovascular drugs such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized by 2 weeks before starting this drug. Considering the patient's condition, gradually increase the dose at 1~2-week intervals until the optimal dose for each patient is reached. Start treatment with 1.25mg of nebivolol once daily and, if necessary, increase the dose to 2.5mg once daily, 5mg once daily, and up to 10mg once daily. The maximum daily dose is 10mg. It may be taken with food. 2) Patients with renal impairment Since titration to the maximum tolerated dose is adjusted for each patient, no dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine≥250μmol/L), as there is no experience with its use in these patients.

Ingredients

Manufacturer
Allico Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and adjunctive treatment of chronic heart failure in patients aged 70 years or older

  • Essential hypertension
  • chronic heart failure
View approved original text

This medication is used to treat essential hypertension and stabilize blood pressure. It is also used adjunctively to standard therapy in patients aged 70 and over with chronic heart failure, especially those with mild to moderate stable chronic heart failure, to improve heart failure symptoms.

How to take

Adult dose

1. Essential hypertension 1) Adults Administer 5mg of nebivolol orally once daily at the same time each day. The blood pressure-lowering effect usually appears after 1~2 weeks of treatment and may, in some cases, appear after 4 weeks. It may be taken with food. 2) Patients with renal impairment The initial dose is 2.5mg of nebivolol administered orally once daily. If necessary, the daily dose may be increased to 5mg. 3) Elderly patients The initial dose in elderly patients aged 65 years and older is 2.5mg of nebivolol once daily. If necessary, the daily dose may be increased to 5mg. Since there is insufficient clinical experience in patients aged 75 years and older, administer with careful monitoring. 2. Chronic heart failure 1) Elderly patients aged 70 years and older This drug should be administered to patients with chronic stable heart failure who have had no history of acute heart failure during the past 6 weeks, and doses of cardiovascular drugs such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized by 2 weeks before starting this drug. Considering the patient's condition, gradually increase the dose at 1~2-week intervals until the optimal dose for each patient is reached. Start treatment with 1.25mg of nebivolol once daily and, if necessary, increase the dose to 2.5mg once daily, 5mg once daily, and up to 10mg once daily. The maximum daily dose is 10mg. It may be taken with food. 2) Patients with renal impairment Since titration to the maximum tolerated dose is adjusted for each patient, no dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine≥250μmol/L), as there is no experience with its use in these patients.

Precautions

This medication should not be used in certain patients. For example, patients who are allergic to this medication, or those with cardiac or pulmonary issues such as bronchial asthma, severe heart failure, and hypotension should not take this medication. Additionally, pregnant or nursing women should not take this medication. This medication contains lactose, so caution is also needed for patients with lactose intolerance. This medication should be used cautiously in individuals with certain conditions like chronic respiratory diseases, uncontrolled heart failure, hyperthyroidism, and diabetes. During treatment, various side effects such as headache, dizziness, bradycardia, hypotension, dyspepsia, shortness of breath, and skin rash may arise, so if any unusual symptoms occur, consult medical personnel immediately. This medication may interact with other drugs, so it is essential to follow medical guidance when taken with calcium channel blockers, antiarrhythmics, central nervous system drugs, insulin, etc. When discontinuing this medication, do not stop abruptly; instead, taper off gradually, and it is safest to discontinue at least 24 hours before surgery. In case of overdose, severe bradycardia, hypotension, bronchospasm, etc., may occur, so immediate emergency treatment is necessary, and professional treatment such as atropine may be required. Elderly patients should start with a low dose and be closely monitored, and safety and efficacy in children have not been established, so it is not recommended.

Side effects

Rash, vision impairment, bradycardia, AV block, AV conduction delay, hypotension, heart failure, intermittent claudication, headache, dizziness, paresthesia, depression, nightmares, syncope, diarrhea, constipation, nausea, dyspepsia, bloating, vomiting, dyspnea, bronchospasm, pruritus, erythematous rash, exacerbation of psoriasis, edema, fatigue, erectile dysfunction, vascular neurogenic edema, hypersensitivity, hallucinations, psychosis, confusion, cyanosis of extremities, dry eyes, practolol-type conjunctival and skin toxicity, Raynaud's phenomenon, orthostatic hypotension, drug intolerance, first-degree atrioventricular block, leg edema, chest burning, insomnia, palpitations, abdominal pain, increased urination, elevated blood sugar, neck/shoulder pain, gastritis, chest pain, weakness, ineffective treatment, weight loss, cough, cold, dry cough, anorexia, anxiety, back pain, increased serum creatinine, tinnitus, vertigo, tremors, neuromuscular disease, gastroesophageal reflux, irritable bowel syndrome, thirst, gastric ulcer, gastrointestinal disorders, general weakness, facial edema, generalized edema, upper respiratory infection, rhinitis, sore throat, runny nose, restlessness, depression, drowsiness, joint pain, flank pain, neck stiffness, back pain, increased BUN, bladder discomfort, cystitis, urinary stones, hematuria, diabetes, urticaria, athlete's foot, sweating, tinea corporis, hypertension, cerebrovascular disease, peripheral vascular disease, flushing, nosebleed, increased ALT, increased AST, viral infection, thyroiditis, chronic myeloid leukemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. This helps retain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.